← All organizations

IST GmbH, Germany

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Sep 12, 2016

Timeline

1990s

Jan 1, 1992
IST GmbH, Germany— Founded

Drugs by trial phase (1 distinct, 1 trials)

Phase 4 (1 own, 0 via acquisition)

adalimumab

Indications

Studied for

Spondylarthritis

Recent trials (1)

NCT02897115CollaboratorPhase 4Sep 12, 2016

Details

Founded: Mannheim, DE Jan 1, 1992
Last known activity: Sep 12, 2016

Notes

CRO